EUVIMEDEUVIMED entdecken
Crossref

P14 Whole-genome sequencing of malignant cylindroma in CYLD cutaneous syndrome reveals a clinically targetable somatic driver mutation

William Fostier, Ching Chiek Koh, Akhtar Husain, Shirin Namini, Serena Nik-Zainal, Neil Rajan

British Journal of Dermatology · 07.07.2023 · 189 (1) · e19-e19

DOI: 10.1093/bjd/ljad174.035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Dermatology, online erschienen am 07.07.2023. Verfasst von William Fostier und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metastatic malignant cylindroma (MC) is a rare skin appendageal cancer for which there are no licensed chemotherapeutic interventions and has poor clinical outcomes. MC arising in CYLD cutaneous syndrome (CCS) has been shown to carry pathogenic variants in CYLD and additional driver mutations in TP53. Here we present whole-genome sequencing (WGS) data from MC in a 29-year-old man, revealing a novel clinically targetable somatic driver mutation. The proband presented with a growing, ulcerated cylindroma on the scalp at 28 years of age. He had previously presented with benign cylindromas on the scalp from 8 years of age, attributed to his mother who had CCS. The proband's father and paternal grandmother both had early breast cancer. The proband's sister, aged 33 years, had been recently diagnosed with breast cancer and CCS. Histology of the ulcerated scalp tumour revealed a biphasic neoplasm, showing malignant cylindroma with high-grade features arising within a pre-existing benign cylindroma. Several weeks following excision of the malignant scalp cylindroma, a nodule presented on the left side of the patient's neck; biopsy of the neck lump revealed histology consistent with the metastatic MC. Radiological imaging revealed metastatic deposits of MC in the right axilla, both lungs and the brain. Genetic testing of the proband revealed germline pathogenic variants in both BRCA2 and CYLD, also present in his sister. WGS of the primary MC showed extensive copy number variation, with loss of heterozygosity involving CYLD and BRCA2 loci, not present in a matched control blood sample. Mutational signatures SBS3 and SBS8 were present, consistent with homologous repair (HR) deficiency, and, in addition, SBS13 was detected, suggesting APOBEC-driven mutagenesis. A high HR detect score of 0.999 was reported, consistent with a BRCA-deficient tumour. Additional driver somatic variants in TP53 and PTEN were also detected and are likely to have contributed to tumour pathogenesis. The BRCA deficiency demonstrated in this patient's MC supports the use of poly ADP ribose polymerase (PARP) inhibitors, which have not previously been used to treat MC. This case emphasizes the importance of recognizing coinheritance of tumour suppressor genes in rare genetic conditions, and the utility of rapid WGS to provide novel management options and improve patient outcomes.

Zitieren

APA

Fostier, W., Koh, C. C., Husain, A., Namini, S., Nik-Zainal, S., & Rajan, N. (2023). P14 Whole-genome sequencing of malignant cylindroma in CYLD cutaneous syndrome reveals a clinically targetable somatic driver mutation. British Journal of Dermatology, 189(1), e19-e19. https://doi.org/10.1093/bjd/ljad174.035

Vancouver

Fostier W, Koh CC, Husain A, Namini S, Nik-Zainal S, Rajan N. P14 Whole-genome sequencing of malignant cylindroma in CYLD cutaneous syndrome reveals a clinically targetable somatic driver mutation. British Journal of Dermatology. 2023;189(1):e19-e19. doi:10.1093/bjd/ljad174.035

BibTeX
@article{Fostier2023,
  author = {Fostier, William and Koh, Ching Chiek and Husain, Akhtar and Namini, Shirin and Nik-Zainal, Serena and Rajan, Neil},
  title = {P14 Whole-genome sequencing of malignant cylindroma in CYLD cutaneous syndrome reveals a clinically targetable somatic driver mutation},
  journal = {British Journal of Dermatology},
  year = {2023},
  volume = {189},
  number = {1},
  pages = {e19--e19},
  doi = {10.1093/bjd/ljad174.035}
}
Kostenlos starten →